Regenxbio Inc (RGNX)
16.06
+0.02
(+0.12%)
USD |
NASDAQ |
Apr 25, 16:00
16.08
+0.02
(+0.12%)
After-Hours: 20:00
Regenxbio Gross Profit (Quarterly): 10.98M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 10.98M |
September 30, 2023 | 16.53M |
June 30, 2023 | 10.50M |
March 31, 2023 | 15.03M |
December 31, 2022 | 18.56M |
September 30, 2022 | 13.42M |
June 30, 2022 | 19.70M |
March 31, 2022 | 6.501M |
December 31, 2021 | 375.60M |
September 30, 2021 | 16.67M |
June 30, 2021 | 12.22M |
March 31, 2021 | 14.03M |
December 31, 2020 | 11.19M |
September 30, 2020 | 81.55M |
June 30, 2020 | 11.88M |
March 31, 2020 | 14.24M |
December 31, 2019 | 7.977M |
September 30, 2019 | 12.21M |
June 30, 2019 | 5.954M |
Date | Value |
---|---|
March 31, 2019 | 0.855M |
December 31, 2018 | 37.93M |
September 30, 2018 | 4.789M |
June 30, 2018 | 36.16M |
March 31, 2018 | 129.98M |
December 31, 2017 | 2.422M |
September 30, 2017 | 0.653M |
June 30, 2017 | 5.245M |
March 31, 2017 | 0.364M |
December 31, 2016 | 1.366M |
September 30, 2016 | 0.09M |
June 30, 2016 | 1.877M |
March 31, 2016 | 0.297M |
December 31, 2015 | 3.566M |
September 30, 2015 | 0.883M |
June 30, 2015 | 1.053M |
March 31, 2015 | 0.591M |
December 31, 2014 | 0.997M |
September 30, 2014 | 0.471M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
5.954M
Minimum
Jun 2019
375.60M
Maximum
Dec 2021
35.51M
Average
13.42M
Median
Sep 2022
Gross Profit (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 352.60M |
Amgen Inc | 5.084B |
Gilead Sciences Inc | 5.024B |
AbbVie Inc | 8.597B |
Bristol-Myers Squibb Co | 8.732B |